Literature DB >> 17009598

Heat shock proteins, end effectors of myocardium ischemic preconditioning?

María Concepcion Guisasola1, Maria del Mar Desco, Fernanda Silvana Gonzalez, Fernando Asensio, Elena Dulin, Antonio Suarez, Pedro Garcia Barreno.   

Abstract

The purpose of this study was to investigate (1) whether ischemia-reperfusion increased the content of heat shock protein 72 (Hsp72) transcripts and (2) whether myocardial content of Hsp72 is increased by ischemic preconditioning so that they can be considered as end effectors of preconditioning. Twelve male minipigs (8 protocol, 4 sham) were used, with the following ischemic preconditioning protocol: 3 ischemia and reperfusion 5-minute alternative cycles and last reperfusion cycle of 3 hours. Initial and final transmural biopsies (both in healthy and ischemic areas) were taken in all animals. Heat shock protein 72 messenger ribonucleic acid (mRNA) expression was measured by a semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) method using complementary DNA normalized against the housekeeping gene cyclophilin. The identification of heat shock protein 72 was performed by immunoblot. In our "classic" preconditioning model, we found no changes in mRNA hsp72 levels or heat shock protein 72 content in the myocardium after 3 hours of reperfusion. Our experimental model is valid and the experimental techniques are appropriate, but the induction of heat shock proteins 72 as end effectors of cardioprotection in ischemic preconditioning does not occur in the first hours after ischemia, but probably at least 24 hours after it, in the so-called "second protection window."

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009598      PMCID: PMC1576469          DOI: 10.1379/csc-181r1.1

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  57 in total

1.  Presence of heat shock protein 72 in cardiomyocytes after heat stress.

Authors:  R N Cornelussen; F A van Nieuwenhoven; L H Snoeckx; A A Knowlton
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

2.  Increased ubiquitin-dependent degradation can replace the essential requirement for heat shock protein induction.

Authors:  Sylvie Friant; Karsten D Meier; Howard Riezman
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

3.  Cardioprotective effects of 70-kDa heat shock protein in transgenic mice.

Authors:  N B Radford; M Fina; I J Benjamin; R W Moreadith; K H Graves; P Zhao; S Gavva; A Wiethoff; A D Sherry; C R Malloy; R S Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 4.  Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis.

Authors:  G Chad Hughes; Mark J Post; Michael Simons; Brian H Annex
Journal:  J Appl Physiol (1985)       Date:  2003-05

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Heat shock proteins and cardiac protection.

Authors:  D S Latchman
Journal:  Cardiovasc Res       Date:  2001-09       Impact factor: 10.787

7.  Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery.

Authors:  J C Plumier; B M Ross; R W Currie; C E Angelidis; H Kazlaris; G Kollias; G N Pagoulatos
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Expression of heat shock protein after ischemic preconditioning in rabbit hearts.

Authors:  M Tanaka; H Fujiwara; K Yamasaki; R Yokota; K Doyama; T Inada; S Ohtani; T Fujiwara; S Sasayama
Journal:  Jpn Circ J       Date:  1998-07

Review 9.  Nitric oxide in myocardial ischemia/reperfusion injury.

Authors:  Rainer Schulz; Malte Kelm; Gerd Heusch
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

Review 10.  Role of apoptosis in reperfusion injury.

Authors:  Frank Eefting; Benno Rensing; Jochem Wigman; Willem Jan Pannekoek; Wai Ming Liu; Maarten Jan Cramer; Daniel J Lips; Pieter A Doevendans
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

View more
  6 in total

Review 1.  Targeted heat shock protein 72 for pulmonary cytoprotection.

Authors:  Missag H Parseghian; Stephen T Hobson; Richard A Richieri
Journal:  Ann N Y Acad Sci       Date:  2016-05-06       Impact factor: 5.691

2.  Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion Injury.

Authors:  Takashi Tanimoto; Missag H Parseghian; Takehiro Nakahara; Hideki Kawai; Navneet Narula; Dongbin Kim; Robert Nishimura; Richard H Weisbart; Grace Chan; Richard A Richieri; Nezam Haider; Farhan Chaudhry; Glenn T Reynolds; John Billimek; Francis G Blankenberg; Partho P Sengupta; Artiom D Petrov; Takashi Akasaka; H William Strauss; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2017-09-19       Impact factor: 24.094

3.  Transcriptional responses in the adaptation to ischaemia-reperfusion injury: a study of the effect of ischaemic preconditioning in total knee arthroplasty patients.

Authors:  Terence Murphy; Pauline M Walsh; Peter P Doran; Kevin J Mulhall
Journal:  J Transl Med       Date:  2010-05-10       Impact factor: 5.531

4.  Upregulation of Hsp72 mediates anoxia/reoxygenation neuroprotection in the freshwater turtle via modulation of ROS.

Authors:  Shailaja Kesaraju; Gauri Nayak; Howard M Prentice; Sarah L Milton
Journal:  Brain Res       Date:  2014-08-05       Impact factor: 3.252

Review 5.  Redox Aspects of Chaperones in Cardiac Function.

Authors:  Claudia Penna; Matteo Sorge; Saveria Femminò; Pasquale Pagliaro; Mara Brancaccio
Journal:  Front Physiol       Date:  2018-03-16       Impact factor: 4.566

6.  Preoperative oral thyroid hormones to prevent euthyroid sick syndrome and attenuate myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass in children: A randomized, double-blind, placebo-controlled trial.

Authors:  Jia-Qiang Zhang; Quan-Yong Yang; Fu-Shan Xue; Wei Zhang; Gui-Zhen Yang; Xu Liao; Fan-Min Meng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.